Literature DB >> 22260773

Stylissamide X, a new proline-rich cyclic octapeptide as an inhibitor of cell migration, from an Indonesian marine sponge of Stylissa sp.

Masayoshi Arai1, Yoshi Yamano, Mayumi Fujita, Andi Setiawan, Motomasa Kobayashi.   

Abstract

A new proline-rich cyclic octapeptide named stylissamide X (1) was isolated from an Indonesian marine sponge of Stylissa sp. as an inhibitor of cell migration from the guidance of wound-healing assay. The chemical structure of stylissamide X (1) was determined on the basis of spectroscopic analysis, and stereostructure of the amino acids were deduced by Marfey's method. Compound 1 showed inhibitory activity against migration of HeLa cells in the ranges of 0.1-10 μM concentration through both wound-healing assay and chemotaxicell chamber assay, while the cell viability was maintained more than 75% up to 10 μM concentration of 1.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22260773     DOI: 10.1016/j.bmcl.2011.10.023

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  10 in total

Review 1.  Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways.

Authors:  Srimanta Patra; Prakash Priyadarshi Praharaj; Debasna Pritimanjari Panigrahi; Biswajit Panda; Chandra Sekhar Bhol; Kewal Kumar Mahapatra; Soumya Ranjan Mishra; Bishnu Prasad Behera; Mrutyunjay Jena; Gautam Sethi; Shankargouda Patil; Samir Kumar Patra; Sujit Kumar Bhutia
Journal:  Mol Biol Rep       Date:  2020-08-14       Impact factor: 2.316

Review 2.  The Pharmacological Potential of Non-ribosomal Peptides from Marine Sponge and Tunicates.

Authors:  Shivankar Agrawal; Alok Adholeya; Sunil K Deshmukh
Journal:  Front Pharmacol       Date:  2016-10-25       Impact factor: 5.810

3.  First Total Synthesis and Biological Screening of a Proline-Rich Cyclopeptide from a Caribbean Marine Sponge.

Authors:  Rajiv Dahiya; Sunil Singh; Ajay Sharma; Suresh V Chennupati; Sandeep Maharaj
Journal:  Mar Drugs       Date:  2016-12-15       Impact factor: 5.118

Review 4.  Natural Proline-Rich Cyclopolypeptides from Marine Organisms: Chemistry, Synthetic Methodologies and Biological Status.

Authors:  Wan-Yin Fang; Rajiv Dahiya; Hua-Li Qin; Rita Mourya; Sandeep Maharaj
Journal:  Mar Drugs       Date:  2016-10-26       Impact factor: 5.118

Review 5.  An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs.

Authors:  Verónica Ruiz-Torres; Jose Antonio Encinar; María Herranz-López; Almudena Pérez-Sánchez; Vicente Galiano; Enrique Barrajón-Catalán; Vicente Micol
Journal:  Molecules       Date:  2017-06-23       Impact factor: 4.411

Review 6.  Marine Bioactive Peptides-An Overview of Generation, Structure and Application with a Focus on Food Sources.

Authors:  Milica Pavlicevic; Elena Maestri; Marta Marmiroli
Journal:  Mar Drugs       Date:  2020-08-13       Impact factor: 5.118

7.  Enzymatic Synthesis Assisted Discovery of Proline-Rich Macrocyclic Peptides in Marine Sponges.

Authors:  Ipsita Mohanty; Nguyet A Nguyen; Samuel G Moore; Jason S Biggs; David A Gaul; Neha Garg; Vinayak Agarwal
Journal:  Chembiochem       Date:  2021-07-08       Impact factor: 3.461

Review 8.  Marine low molecular weight natural products as potential cancer preventive compounds.

Authors:  Valentin A Stonik; Sergey N Fedorov
Journal:  Mar Drugs       Date:  2014-01-27       Impact factor: 5.118

9.  Structures and solution conformational dynamics of stylissamides G and H from the Bahamian sponge Stylissa caribica.

Authors:  Xiao Wang; Brandon I Morinaka; Tadeusz F Molinski
Journal:  J Nat Prod       Date:  2014-02-27       Impact factor: 4.050

10.  New Tricks with an Old Sponge: Feature-Based Molecular Networking Led to Fast Identification of New Stylissamide L from Stylissa caribica.

Authors:  Silvia Scarpato; Roberta Teta; Gerardo Della Sala; Joseph R Pawlik; Valeria Costantino; Alfonso Mangoni
Journal:  Mar Drugs       Date:  2020-08-27       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.